BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 27777306)

  • 1. A Critical Role for β-Catenin in Modulating Levels of Insulin Secretion from β-Cells by Regulating Actin Cytoskeleton and Insulin Vesicle Localization.
    Sorrenson B; Cognard E; Lee KL; Dissanayake WC; Fu Y; Han W; Hughes WE; Shepherd PR
    J Biol Chem; 2016 Dec; 291(50):25888-25900. PubMed ID: 27777306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for PAK1 mediated phosphorylation of β-catenin Ser552 in the regulation of insulin secretion.
    Sorrenson B; Dissanayake WC; Hu F; Lee KL; Shepherd PR
    Biochem J; 2021 Apr; 478(8):1605-1615. PubMed ID: 33605402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The LIM homeodomain protein ISL1 mediates the function of TCF7L2 in pancreatic beta cells.
    Shao W; Szeto V; Song Z; Tian L; Feng ZP; Nostro MC; Jin T
    J Mol Endocrinol; 2018 Jul; 61(1):1-12. PubMed ID: 29678908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Cells retain a pool of insulin-containing secretory vesicles regulated by adherens junctions and the cadherin-binding protein p120 catenin.
    Dissanayake WC; Shepherd PR
    J Biol Chem; 2022 Aug; 298(8):102240. PubMed ID: 35809641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective disruption of Tcf7l2 in the pancreatic β cell impairs secretory function and lowers β cell mass.
    Mitchell RK; Mondragon A; Chen L; Mcginty JA; French PM; Ferrer J; Thorens B; Hodson DJ; Rutter GA; Da Silva Xavier G
    Hum Mol Genet; 2015 Mar; 24(5):1390-9. PubMed ID: 25355422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCF7L2 controls insulin gene expression and insulin secretion in mature pancreatic beta-cells.
    Loder MK; da Silva Xavier G; McDonald A; Rutter GA
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):357-9. PubMed ID: 18481957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-catenin isoforms are regulated by glucose and involved in regulating insulin secretion in rat clonal β-cell models.
    Dissanayake WC; Sorrenson B; Lee KL; Barre S; Shepherd PR
    Biochem J; 2020 Feb; 477(4):763-772. PubMed ID: 32003420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disrupted dynamics of F-actin and insulin granule fusion in INS-1 832/13 beta-cells exposed to glucotoxicity: partial restoration by glucagon-like peptide 1.
    Quinault A; Gausseres B; Bailbe D; Chebbah N; Portha B; Movassat J; Tourrel-Cuzin C
    Biochim Biophys Acta; 2016 Aug; 1862(8):1401-11. PubMed ID: 27101990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adaptor protein APPL2 controls glucose-stimulated insulin secretion via F-actin remodeling in pancreatic β-cells.
    Wang B; Lin H; Li X; Lu W; Kim JB; Xu A; Cheng KKY
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28307-28315. PubMed ID: 33122440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCF7L2 in mouse pancreatic beta cells plays a crucial role in glucose homeostasis by regulating beta cell mass.
    Takamoto I; Kubota N; Nakaya K; Kumagai K; Hashimoto S; Kubota T; Inoue M; Kajiwara E; Katsuyama H; Obata A; Sakurai Y; Iwamoto M; Kitamura T; Ueki K; Kadowaki T
    Diabetologia; 2014 Mar; 57(3):542-53. PubMed ID: 24317852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COUP-TFII controls mouse pancreatic β-cell mass through GLP-1-β-catenin signaling pathways.
    Boutant M; Ramos OH; Tourrel-Cuzin C; Movassat J; Ilias A; Vallois D; Planchais J; Pégorier JP; Schuit F; Petit PX; Bossard P; Maedler K; Grapin-Botton A; Vasseur-Cognet M
    PLoS One; 2012; 7(1):e30847. PubMed ID: 22292058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chikusetsu saponin IVa protects pancreatic β cell against intermittent high glucose-induced injury by activating Wnt/β-catenin/TCF7L2 pathway.
    Cui J; Duan J; Chu J; Guo C; Xi M; Li Y; Weng Y; Wei G; Yin Y; Wen A; Qiao B
    Aging (Albany NY); 2020 Jan; 12(2):1591-1609. PubMed ID: 31969494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insight into the mechanisms underlying the function of the incretin hormone glucagon-like peptide-1 in pancreatic β-cells: the involvement of the Wnt signaling pathway effector β-catenin.
    Xiong X; Shao W; Jin T
    Islets; 2012; 4(6):359-65. PubMed ID: 23314611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
    Lee YS; Jun HS
    Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells.
    da Silva Xavier G; Loder MK; McDonald A; Tarasov AI; Carzaniga R; Kronenberger K; Barg S; Rutter GA
    Diabetes; 2009 Apr; 58(4):894-905. PubMed ID: 19168596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exocyst sec5 regulates exocytosis of newcomer insulin granules underlying biphasic insulin secretion.
    Xie L; Zhu D; Kang Y; Liang T; He Y; Gaisano HY
    PLoS One; 2013; 8(7):e67561. PubMed ID: 23844030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin granule recruitment and exocytosis is dependent on p110gamma in insulinoma and human beta-cells.
    Pigeau GM; Kolic J; Ball BJ; Hoppa MB; Wang YW; Rückle T; Woo M; Manning Fox JE; MacDonald PE
    Diabetes; 2009 Sep; 58(9):2084-92. PubMed ID: 19549714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In pancreatic β-cells myosin 1b regulates glucose-stimulated insulin secretion by modulating an early step in insulin granule trafficking from the Golgi.
    Tokuo H; Komaba S; Coluccio LM
    Mol Biol Cell; 2021 Jun; 32(12):1210-1220. PubMed ID: 33826361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipocyte-specific deletion of Tcf7l2 induces dysregulated lipid metabolism and impairs glucose tolerance in mice.
    Nguyen-Tu MS; Martinez-Sanchez A; Leclerc I; Rutter GA; da Silva Xavier G
    Diabetologia; 2021 Jan; 64(1):129-141. PubMed ID: 33068125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose but not KCl diminishes submembrane granule turnover in mouse beta-cells.
    Brüning D; Reckers K; Drain P; Rustenbeck I
    J Mol Endocrinol; 2017 Oct; 59(3):311-324. PubMed ID: 28765259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.